Urinary Neopterin and Microalbuminuria in Patients Treated by Low-density Lipoprotein Apheresis

Urinary Neopterin and Microalbuminuria in Patients Treated by Low-density Lipoprotein Apheresis

Low-density lipoprotein (LDL)-apheresis is a method of extracorporeal elimination of LDL-cholesterol in patients with severe primary lipoprotein disorders. LDL-cholesterol activates macrophages, which play an important role in atheromatous plaque formation. In the present study, we have investigated...

Full description

Bibliographic Details
Main Authors:	Cermanová Melanie, Melichar Bohuslav, Solichová Dagmar, Bláha Milan, Bláha Vladimir, Blazek Martin, Mašín Vladimir, Cerman Jaroslav, Zadák Zdenek
Format:	Article
Language:	English
Published:	De Gruyter 2005-11-01
Series:	Pteridines
Subjects:	neopterin microalbuminuria ldl-apheresis cholesterol familial hypercholesterolemia
Online Access:	https://doi.org/10.1515/pteridines.2005.16.4.174

Similar Items

Extracorporeal LDL-Cholesterol Elimination in the Treatment of Severe Familial Hypercholesterolemia
by: Milan Bláha
Published: (2003-01-01)

Platelet aggregation and lipoprotein levels in a patient with familial hypercholescholesterolemia after selective LDL-apheresis
by: Madalena Nunes da Silva Pares, et al.

The effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center
by: Muhammet Bulut, et al.
Published: (2020-01-01)

Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
by: Akl C. Fahed, et al.
Published: (2012-11-01)

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
by: Laura D’Erasmo, et al.
Published: (2021-09-01)

Myeloperoxidase modulation by LDL apheresis in Familial Hypercholesterolemia
by: Minichilli Fabrizio, et al.
Published: (2011-10-01)

Urinary Neopterin in Patients with Metastatic Colon Cancer Treated with Patupilone
by: Melichar Bohuslav, et al.
Published: (2011-02-01)

Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients
by: J. Víšek, et al.
Published: (2021-02-01)

Role of lipoprotein apheresis in the management of familial hypercholesterolemia
by: Shamanna Seshadri Iyengar, et al.
Published: (2021-01-01)

Cerebrospinal Fluid Neopterin in Patients with Tumors and other Disorders
by: Rehák Svatopluk, et al.
Published: (2008-02-01)

Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia
by: B.M. Schamberger, et al.
Published: (2000-05-01)

LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)

Urinary Neopterin in Patients with upper Gastrointestinal, Biliary and Pancreatic Carcinomas
by: Melichar Bohuslav, et al.
Published: (2006-02-01)

Urinary Neopterin in Patients with Diabetes Mellitus and Foot Ulcers
by: Melicharova Karolina, et al.
Published: (2007-02-01)

Serial Urinary Neopterin Measurements Reflect the Disease Course in Patients with Epithelial Ovarian Carcinoma Treated with Paclitaxel/Platinum Chemotherapy
by: Melichar Bohuslav, et al.
Published: (2007-02-01)

Urinary neopterin concentrations during radiotherapy for gynecological cancer
by: Trivedi Sachin Vipin, et al.
Published: (2014-04-01)

Prognostic Significance of Serum Neopterin in Patients with Esophageal Carcinoma
by: Cincibuch Jan, et al.
Published: (2012-02-01)

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
by: Tina Z. Khan, et al.
Published: (2021-01-01)

A study of prevalence of microalbuminuria in recently detected type 2 diabetes and its relation to hypertension, dyslipidaemia and obesity
by: Shrikrishna V Acharya
Published: (2020-09-01)

Urinary Neopterin in Patients with Ovarian Cancer
by: Melichar Bohuslav, et al.
Published: (2006-11-01)

Urinary Neopterin in Patients Treated with Gefitinib
by: Kalabova Hana, et al.
Published: (2007-02-01)

Homozygous familial hypercholesterolemia with stenosis of the left anterior descending coronary artery successfully treated with weekly low‐density lipoprotein apheresis for 16 years without percutaneous coronary intervention
by: Takanori Yasu, et al.
Published: (2019-08-01)

Low-density lipoprotein apheresis in a pediatric patient of familial hypercholesterolemia: Primi experientia from a tertiary care center in North India
by: Kanchan Dogra, et al.
Published: (2017-01-01)

Apheresis platelets in additive solution: Is it a good alternative to conventional group-specific apheresis platelets?
by: Amit Agrawal
Published: (2017-01-01)

Profile of apheresis donors at Professor Alberto Antunes University Hospital of the Federal University of Alagoas
by: Laís Pereira Leite de Araújo Loureiro, et al.
Published: (2021-10-01)

Serum Neopterin, Retinol and Alpha-tocopherol in Patients with the Carcinoma of the Esophagus
by: Cincibuch Jan, et al.
Published: (2009-02-01)

Systemic Immune Activation, Anemia and Thrombocytosis in Breast Cancer Patients Treated by Doxorubicin and Paclitaxel
by: Melichar Bohuslav, et al.
Published: (2006-11-01)

Serum Neopterin in Patients with Malignant Melanoma
by: Beneš Petr, et al.
Published: (2009-02-01)

Case Report: Liver Transplantation in Homozygous Familial Hypercholesterolemia (HoFH)—Long-Term Follow-Up of a Patient and Literature Review
by: Matej Mlinaric, et al.
Published: (2020-10-01)

Peripheral blood leukocyte populations and urinary neopterin during chemotherapy in patients with breast cancer
by: Králíčková Pavlína, et al.
Published: (2016-12-01)

Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?
by: Ulrich Julius, et al.
Published: (2020-07-01)

Serum Neopterin and Angiotensin-converting Enzyme In Cancer Patients
by: Melichar Bohuslav, et al.
Published: (1994-11-01)

Salivary neopterin concentrations in patients with cancer of the oral cavity
by: Pink Richard, et al.
Published: (2016-12-01)

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection
by: Julius U
Published: (2016-10-01)

Concentrations of neopterin, kynurenine and tryptophan in wound secretions of patients with breast cancer and malignant melanoma: a pilot study
by: Mergancová Jana, et al.
Published: (2017-12-01)

Just not cosmesis! Role of low-density lipoprotein apheresis in familial hypercholesterolemia: Experience at a newly developed tertiary care institution in Northern India
by: Daljit Kaur, et al.
Published: (2021-01-01)

Microalbuminuria en adolescentes obesos Microalbuminuria present in obese adolescents
by: Regino Piñeiro Lamas, et al.
Published: (2009-06-01)

Urinary Neopterin, Serum Retinol, α-tocopherol and Homocysteine in Breast Cancer Patients During Treatment with Bevacizumab and Chemotherapy
by: Melichar Bohuslav, et al.
Published: (2010-02-01)

Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years
by: Stanislav Filip, et al.
Published: (2020-09-01)

Circulating Vascular Endothelial Growth Factor, C-reactive Protein and Urinary Neopterin Concentrations During dose-dense Chemotherapy
by: Melichar Bohuslav, et al.
Published: (2008-02-01)